CRSP logo

CRISPR Therapeutics AG

CRSP
Healthcare|Biotechnology|CH
$50.07
+1.51 (+3.11%)
Tangible Book / Share
$17.04
Cash / Share
$23.49
Next Earnings Report
Feb 11, 2027
EPS est. -$1.17 · Revenue est. $10.7M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (7)

Jun 2027
Est. completion
P1Cardiovascular
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Jun 2027
Est. completion
P3Sickle Cell Disease
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
Nov 2027
Est. completion
P3Beta-Thalassemia
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
Jul 2028
Est. completion
P1P2Hypertension
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
Jan 2030
Est. completion
P1P2B-cell Lymphoma
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Dec 2031
Est. completion
P1SLE (Systemic Lupus)
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Dec 2033
Est. completion
P1P2Warm Autoimmune Hemolytic Anemia (WAIHA)
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

SEC Filings (52)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 202610-QQuarterly reportDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 19, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 3, 202610-QQuarterly reportDocumentIndex
Aug 3, 20268-KMaterial eventDocumentIndex
Jul 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 5, 2026S-8Employee stock planDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 4, 202610-QQuarterly reportDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
Apr 30, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 21, 2026ARSAnnual report to holdersDocumentIndex
Apr 21, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 2, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 12, 202610-KAnnual reportDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Nov 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Nov 4, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Oct 15, 20258-KMaterial eventDocumentIndex
Oct 15, 2025424B5Offering prospectusDocumentIndex
Aug 4, 202510-QQuarterly reportDocumentIndex
Aug 4, 20258-KMaterial eventDocumentIndex
Jul 17, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jun 26, 20258-KMaterial eventDocumentIndex
Jun 9, 20258-KMaterial eventDocumentIndex
May 19, 2025424B5Offering prospectusDocumentIndex
May 19, 20258-KMaterial eventDocumentIndex
May 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex